Editas Medicine (EDIT) EBT Margin Growth (1y) (2016 - 2025)
Editas Medicine (EDIT) EBT Margin Growth (1y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Editas Medicine |
262.77 Mn |
262.77 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
10.15 Mn |
| Jun 30, 2025 |
1.17 Mn |
| Mar 31, 2025 |
383,431.00 |
| Dec 31, 2024 |
-11,691.00 |
| Sep 30, 2024 |
-10.10 Mn |
| Jun 30, 2024 |
-1.18 Mn |
| Mar 31, 2024 |
-497,698.00 |
| Dec 31, 2023 |
89,782.00 |
| Sep 30, 2023 |
13.18 Mn |
| Jun 30, 2023 |
-55,144.00 |
| Mar 31, 2023 |
26,090.00 |
| Dec 31, 2022 |
-59,692.00 |
| Sep 30, 2022 |
-13.21 Mn |
| Jun 30, 2022 |
1.37 Mn |
| Mar 31, 2022 |
13,060.00 |
| Dec 31, 2021 |
24,256.00 |
| Sep 30, 2021 |
-64,563.00 |
| Jun 30, 2021 |
-1.43 Mn |
| Mar 31, 2021 |
-8,590.00 |
| Dec 31, 2020 |
-26,734.00 |
